Novadaq Technologies (NASDAQ:NVDQ; TSX:NDQ) has appointed Robert White to its board.
Mr. White is a medical technology industry veteran with over 25 years of high-level experience gained through numerous leadership positions with Medtronic, Instromedix-LifeWatch, ALARIS Medical Systems, Eli Lilly and General Electric.
He was most recently president and CEO of TYRX, a closely-held company commercializing implantable combination drug/device products designed to reduce surgical site infections, until it was acquired by Medtronic earlier this year.
In a statement, Novadaq president and CEO, Dr. Arun Menawat, said Bob has an accomplished history of sales and marketing, operations, business development and general management success within the medical device industry, and his expertise and guidance will be of great benefit to Novadaq at this important time of company growth.
Mr. White said he has been following Novadaq’s progress for some time. “I am very pleased to be joining the company as it works to build and maintain a powerful new clinical ecosystem that provides relevant imaging solutions for use in multiple points throughout the patient care continuum,” he added.
